Peter S. Kim
Peter S. Kim | |
---|---|
Born | April 1, 1958 |
Alma mater | Cornell University, Stanford University |
Known for | Discovering how proteins cause viral membranes to fuse with cells. |
Scientific career | |
Institutions | MIT, Merck & Co., Inc., Stanford University |
Doctoral advisor | Robert L. Baldwin |
Website | Peter S. Kim Lab at Stanford, Stanford Profiles Peter S. Kim |
Peter S. Kim is an American scientist. He was president of Merck Research Laboratories (MRL), 2003-2013 and is currently Virginia & D.K. Ludwig Professor of Biochemistry at Stanford University, Institute Scholar at Stanford ChEM-H, and Lead Investigator of the Infectious Disease Initiative at the Chan Zuckerberg Biohub.[2][3][4][5]
Early life and education
Kim is of Korean descent. Kim grew up in Ridgewood, New Jersey the son of a single mother, and his first job was in 1974 at a Roy Rogers restaurant, where he earned money to pay for college.[6] Kim earned his A.B. in chemistry at Cornell University in 1979 where he conducted research with the late George P. Hess.[7] He received his Ph.D. in Biochemistry at Stanford University under the guidance of Robert L. ("Buzz") Baldwin.[8] He was then appointed by David Baltimore as one of the early Whitehead Fellows at the Whitehead Institute.[9]
Research career
Later, Kim was a Professor of Biology at Massachusetts Institute of Technology (MIT), a Member of the Whitehead Institute and an Investigator at the Howard Hughes Medical Institute.[10]
Kim is known for his studies of coiled coils and for discovering how proteins cause viral membranes to fuse with cells.[11][12][13][14][15] He has a special interest in HIV/AIDS research and designed compounds that stop membrane fusion by HIV, thereby preventing it from infecting cells, and has pioneered efforts to develop an HIV vaccine based on similar principles. Kim also served as a member of the National Institutes of Health (NIH) AIDS Vaccine Research Committee.[16]
Kim joined Merck Research Laboratories (MRL) in 2001 as executive vice president, Research and Development.[17] He was promoted to president in January 2003.[18] In this role Kim oversaw all of Merck's drug and vaccine research and development activities.
During his tenure, Merck gained approval of more than 20 new medicines and vaccines. These include Januvia (the first DPP-4 inhibitor for type 2 diabetes), Gardasil (the first vaccine for prevention of cervical cancer), Isentress (the first HIV integrase inhibitor), Zostavax (the first vaccine for the prevention of shingles in adults), and Rotateq (an oral vaccine for the prevention of rotavirus infection in infants). He also led the biomarker-based development of Keytruda.[19] In 2013, he retired from Merck and was succeeded by Roger Perlmutter.[20][21] He was appointed to the faculty at Stanford University in 2014.[22]
Kim is a member of the National Academy of Science, the National Academy of Medicine, the National Academy of Engineering, and a fellow of the American Academy of Arts and Sciences.
Awards
- NAS Award in Molecular Biology (1993)
- Eli Lilly Award in Biological Chemistry[23] (1994)
- DuPont Merck Young Investigator Award of the Protein Society (1994)
- Samsung Foundation Ho-Am Prize in Basic Science (1998)
- The Hans Neurath Award of the Protein Society (1999)
- Doctor of Science, Honoris Causa, Pohang University of Science and Technology (2011)
- The Arthur Kornberg and Paul Berg Lifetime Achievement Award in Biomedical Sciences, Stanford University (2018)[24]
Current board memberships and other affiliations
- Medical Advisory Board, Howard Hughes Medical Institute[25]
- Scientific Advisory Working Group, Vaccine Research Center, NIH
Elected memberships
- Member, National Academy of Sciences[26]
- Member, National Academy of Medicine[27] (formerly Institute of Medicine)
- Member, National Academy of Engineering[28]
- Member, American Academy of Arts and Sciences
- Fellow, American Association for the Advancement of Science
- Fellow, American Academy of Microbiology
- Fellow, Biophysical Society
- Member, Korean Academy of Science and Technology
Service
- MIT Corporation, Visiting Committee, Department of Biology, MIT
- HARC (HIV Accessory and Regulatory Complexes) Scientific Advisory Board, University of California, San Francisco
- External Scientific Advisory Board, Harvard Program in Therapeutic Science, Harvard Medical School
References
- ^ Shehu, Amarda (2013). "Computer scientist in profile". ACM SIGBioinformatics Record. 3 (1): 26–27. doi:10.1145/2442662.2442669. ISSN 2331-9291.
- ^ "MERCK RESEARCH LABS CHIEF PETER KIM TO JOIN STANFORD'S DEPARTMENT OF BIOCHEMISTRY". Stanford Engineering. 13 December 2013. Retrieved 27 January 2014.
- ^ "Institute Scholars | ChEM-H". chemh.stanford.edu. Retrieved 2019-02-05.
- ^ "CZ Biohub Scientific Leadership – Chan Zuckerberg Biohub". Retrieved 2019-02-05.
- ^ University, Stanford (2016-10-26). "Biochemist Peter Kim leads Chan Zuckerberg Biohub project". Stanford News. Retrieved 2019-02-20.
- ^ Kim, Dr Peter S. (2001-03-11). "MY FIRST JOB; Howdy, Buckaroo, Here's Your Apron". The New York Times. ISSN 0362-4331. Retrieved 2019-02-20.
- ^ "Seminar to honor biophysicist George Hess April 18". Cornell Chronicle. Retrieved 2019-02-20.
- ^ "Chemistry Tree - Robert Lesh Baldwin". academictree.org. Retrieved 2019-02-20.
- ^ "Whitehead Institute - Fellows Program". wi.mit.edu. Retrieved 2019-02-20.
- ^ "Peter S. Kim's Profile | Stanford Profiles". profiles.stanford.edu. Retrieved 2019-02-20.
- ^ "Kim's Coils | DiscoverMagazine.com". Discover Magazine. Retrieved 2019-02-20.
- ^ Leary, Warren E. (1993-05-21). "A Key to Flu Virus Infection Is Identified". The New York Times. ISSN 0362-4331. Retrieved 2019-02-20.
- ^ Rensberger, Boyce (May 21, 1993). "INFLUENZA'S BURGLARY TOOLS".
- ^ "Scientists Find a Key Weapon Used by H.I.V." archive.nytimes.com. Retrieved 2019-02-20.
- ^ "Key HIV Protein Structure Solved". HHMI.org. Retrieved 2019-02-20.
- ^ "Peter S. Kim's Profile | Stanford Profiles". profiles.stanford.edu. Retrieved 2019-02-20.
- ^ Journal, Gardiner HarrisStaff Reporter of The Wall Street. "Merck Names Biologist From MIT As Head of Research Operations". WSJ. Retrieved 2019-02-20.
- ^ "Merck's New Alchemist". www.bloomberg.com. Retrieved 2019-02-20.
- ^ Shaywitz, David. "The Startling History Behind Merck's New Cancer Blockbuster". Forbes. Retrieved 2019-02-20.
- ^ Thomas, Katie (7 March 2013). "Merck Replaces Its Research Chief". New York Times. Retrieved 30 November 2013.
- ^ "Key Merck official retiring, big shoes to fill". www.bizjournals.com. Retrieved 2019-02-20.
- ^ University, © Stanford; Stanford; California 94305 (2016-06-09). "Merck Research Labs chief Peter Kim to join Biochemistry". Stanford School of Engineering. Retrieved 2019-02-20.
{{cite web}}
: CS1 maint: numeric names: authors list (link) - ^ Eli Lilly Award in Biological Chemistry
- ^ "Stanford Medicine Alumni Awards 2018: Peter Kim | ChEM-H". chemh.stanford.edu. Retrieved 2019-02-05.
- ^ "Medical Advisory Board". HHMI.org. Retrieved 2019-02-05.
- ^ "Ceyer, Kim and Langer are elected to NAS". MIT News. Retrieved 2019-02-05.
- ^ "Whitehead Institute - News - 2000 - Whitehead Members Peter S. Kim and Robert A. Weinberg Elected to the Institute of Medicine". wi.mit.edu. Retrieved 2019-02-05.
- ^ "Professor Peter S. Kim". NAE Website. Retrieved 2019-02-05.
- 1958 births
- American health care businesspeople
- American people of Korean descent
- Businesspeople in the pharmaceutical industry
- Cornell University alumni
- Fellows of the American Academy of Arts and Sciences
- Howard Hughes Medical Investigators
- Living people
- Massachusetts Institute of Technology faculty
- Members of the United States National Academy of Sciences
- Merck people
- People from Ridgewood, New Jersey
- Recipients of the Ho-Am Prize in Science
- Stanford Medical School alumni
- American biochemists